NCCN Announces UC Davis Comprehensive Cancer Center as 31st Member Institution

April 16th 2021

Experts from Northern California-based cancer center to join panels responsible for evidence- based recommendations in NCCN Clinical Practice Guidelines and NCCN Guidelines for Patients, among other resources to improve outcomes for people with cancer.

Hutson Highlights Treatment Journey in Clear Cell RCC Case

April 16th 2021

Courtney Marabella

When considering which frontline option to administer to a patient with renal cell carcinoma, it is important to first understand which risk group they belong to.

TKIs, New Targets Serve as Active Areas of Exploration in Pancreatic and Extrapancreatic NETs

April 16th 2021

Hayley Virgil

Yoomi Lee, MD, discusses the safety profile of surufatinib and highlighted future directions for patients with pancreatic and extrapancreatic neuroendocrine tumors.

Accelerating Advances in NSCLC Underscore the Importance of Accessibility

April 16th 2021

Caroline Seymour

Jacob Sands, MD, discussed current approaches to the treatment of patients with early-stage and locally advanced non–small cell lung cancer.

Unique Landscape of Actionable Pathogenic Variants Unfolds in Breast and Ovarian Cancers in the Caribbean

April 16th 2021

Hayley Virgil

Sophia George, PhD, and Judith E. Hurley, MD, discuss the importance of the genetic association study, challenges faced with launching such an effort, the key findings from the research, and the clinical implications of the data in the Caribbean as well as the United States